BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND LASP1, ENSG00000002834, 3927, Q14847, MLN50, Lasp-1
21 results:

  • 1. Long noncoding RNA PPP1R14B-AS1 imitates microRNA-134-3p to facilitate breast cancer progression by upregulating LIM and SH3 protein 1.
    Zhou L; Zhang L; Guan X; Dong YI; Liu T
    Oncol Res; 2021; 29(4):251-262. PubMed ID: 37303940
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. TRIM15 forms a regulatory loop with the AKT/FOXO1 axis and lasp1 to modulate the sensitivity of HCC cells to TKIs.
    Yang C; Jin X; Liu X; Wu G; Yang W; Pang B; Jiang J; Liao D; Zhang Y
    Cell Death Dis; 2023 Jan; 14(1):47. PubMed ID: 36670097
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Hepatitis B virus X protein increases lasp1 SUMOylation to stabilize HER2 and facilitate hepatocarcinogenesis.
    You H; Yuan D; Li Q; Zhang N; Kong D; Yu T; Liu X; Liu X; Zhou R; Kong F; Zheng K; Tang R
    Int J Biol Macromol; 2023 Jan; 226():996-1009. PubMed ID: 36473530
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Long non-coding RNA (lncRNA) CYTOR promotes hepatocellular carcinoma proliferation by targeting the microRNA-125a-5p/lasp1 axis.
    Liu Y; Geng X
    Bioengineered; 2022 Feb; 13(2):3666-3679. PubMed ID: 35081873
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Hepatitis B virus X protein promotes vimentin expression via LIM and SH3 domain protein 1 to facilitate epithelial-mesenchymal transition and hepatocarcinogenesis.
    You H; Yuan D; Bi Y; Zhang N; Li Q; Tu T; Wei X; Lian Q; Yu T; Kong D; Yang X; Liu X; Liu X; Kong F; Zheng K; Tang R
    Cell Commun Signal; 2021 Mar; 19(1):33. PubMed ID: 33722250
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Increased long noncoding RNA lasp1-AS is critical for hepatocellular carcinoma tumorigenesis via upregulating lasp1.
    Yin L; Chen Y; Zhou Y; Deng G; Han Y; Guo C; Li Y; Zeng S; Shen H
    J Cell Physiol; 2019 Aug; 234(8):13493-13509. PubMed ID: 30677131
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. HBX protein promotes lasp-1 expression through activation of c-Jun in human hepatoma cells.
    You H; Kong F; Zhou K; Wei X; Hu L; Hu W; Luo W; Kou Y; Liu X; Chen X; Zheng K; Tang R
    J Cell Physiol; 2018 Sep; 233(9):7279-7291. PubMed ID: 29600594
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. MicroRNA-326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 1.
    Hu S; Ran Y; Chen W; Zhang Y; Xu Y
    Oncol Rep; 2017 Sep; 38(3):1569-1578. PubMed ID: 28713953
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Bioinformatics analysis of the proteins interacting with lasp-1 and their association with HBV-related hepatocellular carcinoma.
    Kong FY; Zhu T; Li N; Cai YF; Zhou K; Wei X; Kou YB; You HJ; Zheng KY; Tang RX
    Sci Rep; 2017 Mar; 7():44017. PubMed ID: 28266596
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. MicroRNA-133b Inhibits Proliferation, Cellular Migration, and Invasion via Targeting lasp1 in Hepatocarcinoma Cells.
    Li H; Xiang Z; Liu Y; Xu B; Tang J
    Oncol Res; 2017 Sep; 25(8):1269-1282. PubMed ID: 28117027
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Predictive value of tumor markers in patients with recurrent hepatocellular carcinoma in different vascular invasion pattern.
    Gao F; Zhu HK; Zhu YB; Shan QN; Ling Q; Wei XY; Xie HY; Zhou L; Xu X; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2016 Aug; 15(4):371-7. PubMed ID: 27498576
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. lasp-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway.
    Li Z; Chen Y; Wang X; Zhang H; Zhang Y; Gao Y; Weng M; Wang L; Liang H; Li M; Zhang F; Zhao S; Liu S; Cao Y; Shu Y; Bao R; Zhou J; Liu X; Yan Y; Zhen L; Dong Q; Liu Y
    Cancer Lett; 2016 Mar; 372(2):239-50. PubMed ID: 26797416
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Molecular characterization of lasp-1 expression reveals vimentin as its new partner in human hepatocellular carcinoma cells.
    Salvi A; Bongarzone I; Ferrari L; Abeni E; Arici B; De Bortoli M; Scuri S; Bonini D; Grossi I; Benetti A; Baiocchi G; Portolani N; De Petro G
    Int J Oncol; 2015 May; 46(5):1901-12. PubMed ID: 25760690
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Early enteral nutrition after total gastrectomy for gastric cancer.
    Chen W; Zhang Z; Xiong M; Meng X; Dai F; Fang J; Wan H; Wang M
    Asia Pac J Clin Nutr; 2014; 23(4):607-11. PubMed ID: 25516318
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (lasp1) in high-risk prostate cancer thereby increasing cell proliferation and migration.
    Hailer A; Grunewald TG; Orth M; Reiss C; Kneitz B; Spahn M; Butt E
    Oncotarget; 2014 Jun; 5(12):4144-4153. PubMed ID: 24980827
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®).
    Poynard T; Vergniol J; Ngo Y; Foucher J; Munteanu M; Merrouche W; Colombo M; Thibault V; Schiff E; Brass CA; Albrecht JK; Rudler M; Deckmyn O; Lebray P; Thabut D; Ratziu V; de Ledinghen V; ; ;
    J Hepatol; 2014 Apr; 60(4):706-14. PubMed ID: 24291240
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma.
    Wang H; Li W; Jin X; Cui S; Zhao L
    Eur J Cancer; 2013 Mar; 49(4):974-83. PubMed ID: 23084841
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Systematic review of neoadjuvant transarterial chemoembolization for resectable hepatocellular carcinoma.
    Chua TC; Liauw W; Saxena A; Chu F; Glenn D; Chai A; Morris DL
    Liver Int; 2010 Feb; 30(2):166-74. PubMed ID: 19912531
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Proteomic identification of lasp-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells.
    Salvi A; Bongarzone I; Miccichè F; Arici B; Barlati S; De Petro G
    Neoplasia; 2009 Feb; 11(2):207-19. PubMed ID: 19177205
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. LIM and SH3 protein 1 (lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinoma.
    Wang B; Feng P; Xiao Z; Ren EC
    J Hepatol; 2009 Mar; 50(3):528-37. PubMed ID: 19155088
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.